Rhino-orbital mucormycosis in COVID-19 patients—a new threat?
| Autor: | Som Subhro Biswas, Sampreet Kaur Awal, Sandeep Singh Awal |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19) Antifungal drugs R895-920 030218 nuclear medicine & medical imaging Medical physics. Medical radiology. Nuclear medicine Black turbinate sign 03 medical and health sciences 0302 clinical medicine Case report otorhinolaryngologic diseases Mucormycosis Medicine Radiology Nuclear Medicine and imaging In patient 0303 health sciences 030306 microbiology business.industry Orbital compartment Surgical debridement COVID-19 medicine.disease eye diseases Surgery Paranasal sinuses medicine.anatomical_structure business Orbital mucormycosis MRI |
| Zdroj: | The Egyptian Journal of Radiology and Nuclear Medicine The Egyptian Journal of Radiology and Nuclear Medicine, Vol 52, Iss 1, Pp 1-6 (2021) |
| ISSN: | 2090-4762 |
| DOI: | 10.1186/s43055-021-00535-9 |
| Popis: | Background Coronavirus disease 2019 (COVID-19) is known to be associated with a myriad of viral, fungal, and bacterial co-infections. Rhino-orbital mucormycosis is a rare angio-invasive fungal infection which has shown a rising trend in the setting of COVID-19. Case presentation We describe the imaging findings in 3 cases of rhino-orbital mucormycosis in patients with history of COVID-19. All cases had varying involvement of paranasal sinuses extending into the orbital compartment while case 3 had intracranial extension of infection. Conclusions Rhino-orbital mucormycosis can have aggressive necrosis of the involved paranasal sinuses and orbits with or without cerebral extension. Hence, the correct diagnosis is imperative as prompt antifungal drugs and surgical debridement can significantly reduce mortality and morbidity. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink